Skip to main navigation Skip to search Skip to main content

Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α

  • Dennis L. Buckley
  • , Jeffrey L. Gustafson
  • , Inge Van-Molle
  • , Anke G. Roth
  • , Hyun Seop Tae
  • , Peter C. Gareiss
  • , William L. Jorgensen
  • , Alessio Ciulli
  • , Craig M. Crews
  • Yale University
  • University of Cambridge

Research output: Contribution to journalArticlepeer-review

279 Scopus citations

Abstract

By design: Novel small-molecule inhibitors of the interaction between the von Hippel-Lindau ligase (VHL) and its molecular target HIF1α, a transcription factor involved in oxygen sensing, have been developed and studied. The most potent inhibitor binds with an IC50 value of 0.9-μM and is thus the first sub-micromolar inhibitor of the VHL-HIF1α interaction.

Original languageEnglish
Pages (from-to)11463-11467
Number of pages5
JournalAngewandte Chemie - International Edition
Volume51
Issue number46
DOIs
StatePublished - Nov 12 2012

Keywords

  • drug design
  • E3 ubiquitin ligases
  • protein crystallography
  • protein-protein interactions
  • structure-based design

Fingerprint

Dive into the research topics of 'Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α'. Together they form a unique fingerprint.

Cite this